Vyxeos
Total Payments
$70,725
Transactions
68
Doctors
10
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $1,650 | 1 | 0 |
| 2018 | $6,887 | 5 | 0 |
| 2017 | $62,188 | 62 | 10 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $60,000 | 15 | 84.8% |
| Travel and Lodging | $7,719 | 27 | 10.9% |
| Unspecified | $1,650 | 1 | 2.3% |
| Food and Beverage | $1,356 | 25 | 1.9% |
Payments by Type
General
$69,075
67 transactions
Research
$1,650
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TREATMENT PRACTICES AND OUTCOMES OF ADULTS WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA (AML) AND AML WITH MYELODYSPLASIA RELATED CHANGES | Jazz Pharmaceuticals Inc. | $1,650 | 0 |
Top Doctors Receiving Payments for Vyxeos
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Joseph Bailes | — | Austin, TX | $44,216 | 18 |
| Bart Scott | Medical Oncology | Seattle, WA | $4,029 | 7 |
| , M.D | Medical Oncology | Philadelphia, PA | $3,524 | 7 |
| , MD | Hematology & Oncology | Beachwood, OH | $3,305 | 13 |
| , M.D | Hematology | Cincinnati, OH | $2,499 | 4 |
| , MD | Hematology & Oncology | Detroit, MI | $2,497 | 4 |
| , MD | Hematology | Chicago, IL | $2,131 | 3 |
| , M.D | Hematology & Oncology | Cleveland, OH | $2,131 | 3 |
| , M.D | Hematology | Chicago, IL | $2,131 | 3 |
| Olatoyosi Odenike | Hematology & Oncology | Chicago, IL | $2,131 | 3 |
| , M.D | Medical Oncology | Allentown, PA | $2,131 | 3 |
Ad
Manufacturing Companies
- Jazz Pharmaceuticals Inc. $70,725
Product Information
- Type Drug
- Total Payments $70,725
- Total Doctors 10
- Transactions 68
About Vyxeos
Vyxeos is a drug associated with $70,725 in payments to 10 healthcare providers, recorded across 68 transactions in the CMS Open Payments database. The primary manufacturer is Jazz Pharmaceuticals Inc..
Payment data is available from 2017 to 2020. In 2020, $1,650 was paid across 1 transactions to 0 doctors.
The most common payment nature for Vyxeos is "Consulting Fee" ($60,000, 84.8% of total).
Vyxeos is associated with 1 research study, including "TREATMENT PRACTICES AND OUTCOMES OF ADULTS WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA (AML) AND AML WITH MYELODYSPLASIA RELATED CHANGES" ($1,650).